Navengage, founded by Penn State alumni Andrew Strause, Dan Lordan, and Colleen McBride, created the Engagement App to be a virtual hub for student information across all Penn State campuses.
Navengage, founded by Penn State alumni Andrew Strause, Dan Lordan, and Colleen McBride, created the Engagement App to be a virtual hub for student information across all Penn State campuses.
Normal pressure hydrocephalus (NPH) is a disease resulting from too much cerebrospinal fluid around the brain and affects roughly 750,000 Americans, typically those over 65 years old. Penn State researchers are developing a new technology called HydroFix, an advanced surgical shunt system to address NPH.
Winning startup works to increase speed to market for some pharmaceuticals psu.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from psu.edu Daily Mail and Mail on Sunday newspapers.
Penn State startup aims to improve treatment of hydrocephalus
Normal pressure hydrocephalus is a disease resulting from too much cerebrospinal fluid around the brain. NPH symptoms are often confused with Alzheimer’s disease but in many cases are reversible with the placement of a shunt. The HydroFix shunt developed by Penn State researchers is designed to mitigate the risks associated with the current shunts on the market and provide a durable treatment solution for NPH patients.Image: Penn State
Penn State startup aims to improve treatment of hydrocephalus
May 28, 2021
UNIVERSITY PARK, Pa. Normal pressure hydrocephalus (NPH) is a disease resulting from too much cerebrospinal fluid (CSF) around the brain and affects roughly 750,000 Americans, typically those over 65 years old. Symptoms are often confused with Alzheimer’s disease, but in many cases they are reversible with the placement of a shunt.